Login to Your Account

Sales growing as drugmakers adapt to post-patent cliff challenges

By Michael Fitzhugh
Staff Writer

Friday, September 5, 2014
Global pharma sales are on track to exceed $1 trillion for the first time in 2014 as drugmakers refine their abilities to explore new scientific opportunities and learn to let go of faltering projects earlier rather than later, according to analysis by CMR International, a Thomson Reuters business.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription